Health Condition 1: null- The patients receiving the any type of available standard or ayurvedic management for cancer with pain as a main symptom with poor quality of life
Conditions
Interventions
Intervention1: Processed powder of Bhanga in capsule form: Experimental studies to decide the dose is underway. The decided dose will be administered along with milk and sugar as adjuvant.
Control Int
Sponsors
IPGT and RA GAU Jamnagar
Ayurved cancer research institute RRA Podar Worli Mumbai CCRAS Ayush MH and FW govt of India
Eligibility
Inclusion criteria
Inclusion criteria: 1) Institutionally diagnosed patients of any type of cancer with pain and ECOG score upto 3. 2) Patients willing to participate in trials. 3) Patients of either sex aged between 18 â?? 70 years 4) Patients undergoing any type of standard palliative treatment for cancer except for pain management.
Exclusion criteria
Exclusion criteria: 1) Systemic diseases like uncontrolled hypertension, uncontrolled diabetes, heart diseases, Lung diseases, hepatic and renal dysfunctions. 2) Pregnancy and breast feeding women. 3) Cancer patients with ECOG more than 3. 4) Patients with inability to comprehend and complete the proposed course study as per instructions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary expected outcome will be reduction in pain and improvement in quality of life and overall associated symptoms in cancer patientsTimepoint: 1 month drug intervention and 1 week follow up | — |
Secondary
| Measure | Time frame |
|---|---|
| Development of shodhit i e purified Bhanga churna in the management of improving quality of life in cancer patients specially as a analgesic agentTimepoint: 1 year | — |
Countries
India
Contacts
Public ContactProf Rabinarayan Acharya
IPGT and RA GAU Jamnagar
Outcome results
None listed